RDHL Stock Price and Chart — NASDAQ:RDHL — TradingView

Compare with Redhill Biopharma Ltd.

Key stats

Upcoming earnings

Company info

RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. The firm's products include Talicia, Movantik, and Aemcolo. It operates through the Commercial Operations and Research and Development segments. The Commercial Operations segment covers areas relating to commercial sales through a subsidiary in the United States. The Research and Development segment includes the study and licensing of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Ideas

RDHL has a fresh catalyst and lots of eyes on it Although not my favorite type of play, this mid-float stock has a VERY VOLATILE chart and has made BIG RUNS in the past... followed by BIG DROPS! IF momentum comes in, we are about to break an important level that could push this stock passed .80's... then ANYTHING can happen. INTRADAY play for me

by CandyMan_Trader

RDHL Stock (Redhill Biopharma Ltd. - American Depositary Shares RedHill Biopharma files to sell 8.86M American Depositary Shares for holders

RDHL | Good Entry Point | LONG RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobac

by DivergenceSeeker

Break out for Redhill Biopharma (RDHL)See chart

by coldsteel_trading

NASDAQ: RDHL / RedHill Biopharma Ltd Hi. Look at this beauty. If you want new shares, like wildly and follow wildly. It is my personal opinion. It isn't investment advice.

by UnknownUnicorn7851950

RDHL, enters Downtrend as Momentum drops below 0 level 09/29/20 This indicator may be signaling that RDHL's price has further to drop, since it fell below its price logged 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options. Tickeron A.I.dvisor backtested 85 similar cases where RDHL's Momentum Indicator fell below th

RedHill Biopharma Announces Positive Recommendation from Indepen RDHL: RedHill Biopharma Ltd. 2020-08-27 07:00:10 RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy

by RocketTickers

RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 St RDHL: RedHill Biopharma Ltd. 2020-07-31 07:00:10 RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 Study with RHB-204 for NTM Infections

by RocketTickers

RDHL Long Personally I think the stock is forming a pullback before another surge, I do believe this stock has the potential to reach $20 in the future.

$RDHL - The "Savior" 6.5$Resistance 7.7, and above is 8. Not for a suggestion Just an Idea.

by Samuel12_1980

See all ideas

Technicals

Summarizing what the indicators are suggesting.

Oscillators

Neutral

Oscillators

Neutral

Summary

Neutral

Summary

Neutral

Summary

Neutral

Moving Averages

Neutral

Moving Averages

Neutral

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.